Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | ABHD16A | O95870 | 1/20 | 0.45 |
| ▸ | PRKCA | P17252 | 4/20 | 0.45 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | FASN | P49327 | 1/20 | 0.42 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.41 |
| ▸ | PRKCG | P05129 | 1/20 | 0.41 |
| ▸ | PRKCB | P05771 | 1/20 | 0.41 |
| ▸ | PRKCH | P24723 | 1/20 | 0.41 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.41 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.41 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.41 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3887138 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15656548 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15657689 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15655302 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15659839 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL6580106 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15658403 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15660716 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL4653719 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL3923431 | 0.98 | CYP1A2 (0.48) | CYP1A2CES2ABHD16APRKCADAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2735581-B1 | COMPOSITION AND POLYMER | ASAHI CHEMICAL IND (JP) | 2021-07-14 | — | — | EP | disclosed |
| US-9738757-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20160222168-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-08-04 | — | — | US | disclosed |
| US-9334371-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-05-10 | — | — | US | disclosed |
| US-20150175568-A1 | KETAL AMIDE COMPOUNDS, METHODS OF MAKING, AND APPLICATIONS | GFBIOCHEMICALS LIMITED (MT) | 2015-06-25 | — | — | US | disclosed |
| US-8969559-B2 | Ketal amide compounds, methods of making, and applications | SEGETIS, INC. (US) | 2015-03-03 | — | — | US | disclosed |
| EP-2735581-A1 | COMPOSITION AND POLYMER | Asahi Kasei Chemicals Corporation (JP) | 2014-05-28 | — | — | EP | disclosed |
| US-20140121293-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-05-01 | — | — | US | disclosed |
| US-20130053564-A1 | KETAL AMIDE COMPOUNDS, METHODS OF MAKING, AND APPLICATIONS | SEGETIS, INC. (US) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053564-A1 | KETAL AMIDE COMPOUNDS, METHODS OF MAKING, AND APPLICATIONS | KAT6A, KAT6B, KAT5 | CYP1A2 2367/4885CES2 334/4885ABHD16A 434/4885 |
| US-20150175568-A1 | KETAL AMIDE COMPOUNDS, METHODS OF MAKING, AND APPLICATIONS | KAT6A, KAT6B, KAT5 | CYP1A2 2367/4885CES2 334/4885ABHD16A 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.